Balaxi Pharmaceuticals Ltd.
BALAXI Share PriceTrading
₹34.97
0.6 (1.8%)
As on December 4, 2025
Exchange Scrips: BSENSEBALAXIISININE618N01022
Market Cap ₹ 192 Cr
P/E Ratio 53.61
Dividend Yield N/A
Performance
Market performance
Open35
High35.44
Volumes76,377
Prev34.97
Low34.02
As on2025-12-04
Historical performance
1 Year High85.58
3 Year High151.45
5 Year High151.45
1 Year Low34
3 Year Low34
5 Year Low34
Fundamentals
Company Valuation
Market Cap (₹Cr)
192
Face Value (₹)
2
P/E Ratio
53.61
Dividend Yield
N/A
Investment Returns
1 Year
-57.7%
3 Years
-69.9%
5 Years
-73%
10 Years
1065.7%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 35.6 | Bearish |
| 10-DMA | 36.6 | Bearish |
| 20-DMA | 37.39 | Bearish |
| 50-DMA | 40.74 | Bearish |
| 100-DMA | 44 | Bearish |
| 200-DMA | 50.69 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 3 | 3 | 3 | 3 | 3 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 3 | 3 | 3 | 3 | 3 |
| Public Investors | 14617 | 13734 | 9991 | 8526 | 7860 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 53.61.
- 3Y Stock Price CAGR of the stock is -33.1.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹80 Million.
- The company generated revenue of ₹610 Million in the previous financial year.
Balaxi Pharmaceuticals Ltd.
34.970.6 (1.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 416607.1
No. of Shares: 11913 (Approx)
Performance:-58.3%
P/L: ₹-583392.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
